Sino Biopharmaceutical Limited (HKG:1177)
Hong Kong · Delayed Price · Currency is HKD 7.47
+0.22 (3.03%)
Aug 5, 2025, 3:52 PM HKT
Sino Biopharmaceutical Market Cap
Sino Biopharmaceutical has a market cap or net worth of 129.66 billion as of August 4, 2025. Its market cap has increased by 149.86% in one year.
Market Cap
129.66B
Enterprise Value
135.74B
Revenue
30.72B
Ranking
n/a
PE Ratio
64.95
Stock Price
7.47
Market Cap Chart
Since September 29, 2000, Sino Biopharmaceutical's market cap has increased from 329.97M to 129.66B, an increase of 39,195.24%. That is a compound annual growth rate of 27.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2025 | 129.66B | 122.57% |
| Dec 31, 2024 | 58.26B | -8.75% |
| Dec 29, 2023 | 63.85B | -24.41% |
| Dec 30, 2022 | 84.46B | -17.53% |
| Dec 31, 2021 | 102.41B | -27.33% |
| Dec 31, 2020 | 140.92B | 3.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 278.50B |
| Hansoh Pharmaceutical Group Company | 207.51B |
| Innovent Biologics | 158.98B |
| JD Health International | 156.01B |
| Akeso | 140.29B |
| WuXi Biologics | 127.57B |
| CSPC Pharmaceutical Group | 113.07B |
| Sichuan Kelun-Biotech Biopharmaceutical | 92.61B |